Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iRhythm Holdings (IRTC) Common Equity (2016 - 2025)

Historic Common Equity for iRhythm Holdings (IRTC) over the last 11 years, with Q3 2025 value amounting to $121.9 million.

  • iRhythm Holdings' Common Equity rose 6984.78% to $121.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $121.9 million, marking a year-over-year increase of 6984.78%. This contributed to the annual value of $90.9 million for FY2024, which is 5673.05% down from last year.
  • As of Q3 2025, iRhythm Holdings' Common Equity stood at $121.9 million, which was up 6984.78% from $103.7 million recorded in Q2 2025.
  • iRhythm Holdings' Common Equity's 5-year high stood at $309.6 million during Q1 2021, with a 5-year trough of $71.8 million in Q3 2024.
  • For the 5-year period, iRhythm Holdings' Common Equity averaged around $194.7 million, with its median value being $221.8 million (2023).
  • As far as peak fluctuations go, iRhythm Holdings' Common Equity soared by 15981.55% in 2021, and later crashed by 6734.87% in 2024.
  • iRhythm Holdings' Common Equity (Quarter) stood at $279.5 million in 2021, then decreased by 14.2% to $239.8 million in 2022, then dropped by 12.39% to $210.1 million in 2023, then plummeted by 56.73% to $90.9 million in 2024, then surged by 34.08% to $121.9 million in 2025.
  • Its Common Equity stands at $121.9 million for Q3 2025, versus $103.7 million for Q2 2025 and $86.7 million for Q1 2025.